Radial 2 Visceral
R2V, Radial to Visceral, offers some advantages over transfemoral access including ambulation immediately after the intervention and fewer access site complications2, allowing the possibility of shorter hospital stays.3
Research on R2V applied to hepatic interventional oncology, uterine fibroid embolization, prostate artery embolization, renal, and peripheral intervention demonstrated R2V was technically successful in 98.2% of the cases, complication rate (Hematoma and/or bleeding) was 0.86% and the overall complication rate was witnessed in 2.51% of cases.In addition, the widespread application of R2V to cancer therapy is anticipated to realize lower invasive therapy with higher safety and cost-effectiveness5.
Radifocus™ Guide Wire GT With Gold Coil
Radifocus™ Guide Wire M Standard Type
Radifocus™ Guide Wire M Stiff Type
Radial access is an evolving field, where the global experiences may help you in your daily practice. Discover Best practice in R2V from Prof. Guimaraes, Professor Medical University of South Carolina, US
Discover our clinical evidence and case studies concerning this topic.
Featured products: Glidesheath Slender™ Introducer, TR Band™ Radial Artery Compression Device
Featured product: Glidesheath Slender™ Introducer
Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter
Featured products: LifePearl™ Drug Elutable Microspheres, Occlusafe™ Temporary Occlusion Balloon Microcatheter
Mauris sed purus volutpat, convallis nibh ac, feugiat lorem. Sed dignissim arcu eulala.
Our sales representatives are here for you.
Thank you for contacting us!
We typically respond within 2 business days and will come back to you as soon as possible.
This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public
For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.
This is HCP only content
website and cannot be refused. Other cookies are only placed if you choose to do so. For further information, please read our cookies policy.
Essential cookies to ensure the website functions well.
Cookies to help us measure the general use of our website.
Cookies that save personal information while browsing.